Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
    • Semiconductors
  • Disclosures
    • Semiconductors
    • Energy
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form
  • [Disclosure] Samsung Biologics (207940) – (Correction) Single Sales and Supply Contract / 2025-12-04 Disclosures
  • [Disclosure] Samsung Biologics (207940) – Single Sales and Supply Contract (Voluntary Disclosure) / 2025-08-26 Disclosures
  • [Disclosure] Celltrion (068270) – Approval of European Commission Marketing Authorization for Avtozma (CT-P47, Actemra/RoActemra Biosimilar) / 2025-02-24 Disclosures
  • [Disclosure] Hanmi Semiconductor (042700) – Record Date for General Meeting of Shareholders / 2024-12-16 Disclosures
  • [Disclosure] Hanwha Systems (272210) – Investor Relations (IR) Holding / 2025-10-31 Disclosures
  • [Disclosure] Hanwha Ocean (042660) – Decision on Capital Increase by Subsidiary / 2025-02-18 Disclosures
  • [Disclosure] SK Square (402340) – Decision on Disposal of Treasury Shares / 2025-01-23 Semiconductors
  • [Disclosure] Hanwha Aerospace (012450) – Execution of Sales/Supply Contract / 2026-04-10 Disclosures

[Disclosure] Hanwha Aerospace (012450) – (Correction) Decision on Acquisition of Shares and Equity Securities of Other Corporation / 2026-07-08

Posted on July 8, 2026August 9, 2026 By K-STOCK Editor

Fact Source: Financial Supervisory Service DART

💡 3-Second Summary

Hanwha Aerospace has disclosed corrected acquisition details—including the updated acquisition amount, number of shares, ownership ratio, and expected acquisition date—regarding its open-market purchase of Korea Aerospace Industries (KAI) shares.

📊 [Key Disclosure Contents & Summary of Major Figures]

  • Disclosure Type: (Correction) Decision on Acquisition of Shares and Equity Securities of Other Corporation
  • Original Disclosure Filing Date: June 16, 2026
  • Reason for Correction: Modification of acquisition details (number of shares, acquisition amount, expected date)
  • Target Company: KOREA AEROSPACE INDUSTRIES, LTD.
  • Purpose of Acquisition: Strengthening business cooperation
  • Acquisition Method: Cash acquisition (Open-market purchase)

[Comparison of Key Corrected Figures]

  • Number of Shares Acquired: (Before) 3,387,533 shares ➔ (After) 3,318,057 shares
  • Acquisition Amount: (Before) KRW 500,000,000,000 ➔ (After) KRW 499,873,994,400 (approx. KRW 499.87B)
  • Total Shares & Ownership After Acquisition: (Before) 9,722,321 shares (9.97%) ➔ (After) 9,652,845 shares (9.90%) (Includes existing 6,334,788 shares)
  • Expected Acquisition Date: (Before) December 31, 2026 ➔ (After) July 8, 2026

[Other Detailed Financial Figures]

  • Acquisition Amount / Total Equity Ratio: 2.98% (Total Equity: approx. KRW 16.79T)
  • Acquisition Amount / Total Assets Ratio: 0.93% (Total Assets at FY-end: approx. KRW 53.95T)
  • Board Resolution Date: June 16, 2026 (5 Outside Directors attended, 0 absent)
  • Target Company (KAI) FY2025 Financial Summary:
    • Total Assets: KRW 10,370,256,890,187 (approx. KRW 10.37T)
    • Total Liabilities: KRW 8,472,910,028,151 (approx. KRW 8.47T)
    • Total Equity: KRW 1,897,346,862,036 (approx. KRW 1.90T)
    • Revenue: KRW 3,696,379,351,601 (approx. KRW 3.70T)
    • Net Income: KRW 187,312,615,904 (approx. KRW 187.31B)

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 Verification of Corrected Equity Ratio and Investments in Other Corporations

This corrected disclosure reflects modifications to the total acquisition cost (approx. KRW 499.87B), share count, ownership percentage (9.90%), and expected acquisition date. Checking the adjusted share count and updated ownership ratio against previous plans is important for understanding the company’s recorded shareholdings. Details regarding updated equity holdings can be verified in the ‘Financial Matters’ and ‘Investments in Other Corporations’ sections of upcoming quarterly, half-yearly, or annual reports.

📢 Disclaimer & Source Information

Source: This content was newly structured and created based on official submission data from the Financial Supervisory Service DART.

Investment Risk Notice: This content is provided for informational and language reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest solely with the investor.

Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Disclosures, Defense

Post navigation

Previous Post: [Research] Samsung Electronics (005930) – IBK Securities | Memory ASP Surge · HBM4 Ramp-Up · Target Price Upgrade / 2026-07-08
Next Post: [Research] Samsung Electro-Mechanics (009150) – Yuanta Securities | Dual Up-cycle · Large-Scale CapEx · Target Price Upgrade / 2026-07-08

Related Posts

  • [Disclosure] Samsung Electronics (005930) – Provisional Consolidated Financial Results (Fair Disclosure) / 2025-04-08 Semiconductors
  • [Disclosure] Hanwha Ocean (042660) – Clarification on Rumors or Reports (Unconfirmed) / 2024-04-02 Disclosures
  • [Disclosure] ALTEOGEN (196170) – (Correction) Decision on Acquisition of Shares and Investment Certificates of Other Corporations / 2024-11-29 Disclosures
  • [Disclosure] Hanmi Semiconductor (042700) – Modification of Listing (Stock Retirement) / 2025-06-13 Semiconductors
  • [Disclosure] KEPCO (015760 / KEP) – (Correction) Decision to Guarantee Debt for Others / 2025-07-24 Disclosures
  • [Disclosure] Celltrion (068270) – Execution of License-in Agreement for Microbiome Gut Disease Drug Candidates / 2026-03-25 Disclosures
  • [Research] SK hynix (000660 / SKHY) – Kiwoom | Commodity Memory Pricing · Server Demand · Earnings Upgrades / 2026-01-30 Semiconductors
  • [Disclosure] Hanmi Semiconductor (042700) – Investor Relations (IR) Presentation / 2024-05-23 Semiconductors
  • [Disclosure] ALTEOGEN (196170) – Execution of Exclusive License Agreement for Human Hyaluronidase Core Technology (ALT-B4) / 2025-03-17 Disclosures
  • [Disclosure] Celltrion (068270) – Final Marketing Authorization Granted by European Commission (EC) for Steqeyma (CT-P43, Stelara Biosimilar) / 2024-08-26 Disclosures
  • [Disclosure] Hanwha Ocean (042660) – Results of Annual General Meeting of Shareholders / 2025-03-20 Disclosures
  • [Disclosure] SK Hynix (000660 / SKHY) – Decision on Record Date for Cash/In-Kind Dividend / 2025-01-23 Semiconductors
  • [Disclosure] Hanwha Aerospace (012450) – Supply Contract / 2025-04-03 Disclosures
  • [Disclosure] SK hynix (000660 / SKHY) – Decision on Closure of Shareholders’ Register (Record Date) for Cash and In-Kind Dividend / 2025-04-23 Semiconductors

Copyright © 2026 K-Stock Briefing.

Powered by PressBook News Dark theme